Harry Relouw
Directeur Général chez Basic Pharma Holding BV
Profil
Harry Relouw is currently the Chairman-Management Board, CFO & General Manager at Basic Pharma Holding BV since 2012.
He is also the Chief Financial Officer & Director at Matisse Pharmaceuticals BV.
In the past, he worked as the Director Finance & Control at Prosensa Holding NV from 2009 to 2012 and as the Chief Financial Officer at Rhein Biotech NV from 1999 to 2003.
Postes actifs de Harry Relouw
| Sociétés | Poste | Début |
|---|---|---|
Basic Pharma Holding BV
 Basic Pharma Holding BV Pharmaceuticals: OtherHealth Technology Basic Pharma Holding BV develops, manufactures, and distributes pharmaceutical products and forms. It offers registered and investigational medicinal products and products by route of administration. It also provides process and product development, quality assurance, regulatory, pharmacovigilance, clinical trial, and laboratory services. The company was founded by Bob Kool and Jacques Havermans in 2003 and is headquartered in Geleen, the Netherlands. | Directeur Général | 01/01/2012 |
Matisse Pharmaceuticals BV
 Matisse Pharmaceuticals BV BiotechnologyHealth Technology Matisse Pharmaceuticals BV engages in the development of therapeutic product for the treatment of sepsis. It offers The company was founded in 2014 and is headquartered in Geleen the Netherlands. | Directeur Financier/CFO | - |
Anciens postes connus de Harry Relouw
| Sociétés | Poste | Fin |
|---|---|---|
| PROSENSA HOLDING NV | Directeur Financier/CFO | 01/01/2012 |
Rhein Biotech NV
 Rhein Biotech NV Miscellaneous Commercial ServicesCommercial Services Rhein Biotech NV developed and manufactured pharmaceutical drugs and vaccines. The company provided licenses to vaccines and biopharmaceutical products in the area of respiratory travel and hepatitis B/pediatric. Rhein Biotech was headquartered in Maastricht, the Netherlands. | Directeur Financier/CFO | 01/01/2003 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Rhein Biotech NV
Rhein Biotech NV Miscellaneous Commercial ServicesCommercial Services Rhein Biotech NV developed and manufactured pharmaceutical drugs and vaccines. The company provided licenses to vaccines and biopharmaceutical products in the area of respiratory travel and hepatitis B/pediatric. Rhein Biotech was headquartered in Maastricht, the Netherlands. | Commercial Services |
Prosensa Holding NV
 Prosensa Holding NV BiotechnologyHealth Technology Prosensa Holding NV engages in the development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company focuses on rare neuromuscular and neurodegenerative disorders, Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. It has developed a portfolio of clinical and pre-clinical RNA-based drug candidates. Prosensa's current clinical portfolio is focused on the treatment of Duchenne Muscular Dystrophy. The company was founded in 2002 and is headquartered in Leiden, the Netherlands. | Health Technology |
Basic Pharma Holding BV
Basic Pharma Holding BV Pharmaceuticals: OtherHealth Technology Basic Pharma Holding BV develops, manufactures, and distributes pharmaceutical products and forms. It offers registered and investigational medicinal products and products by route of administration. It also provides process and product development, quality assurance, regulatory, pharmacovigilance, clinical trial, and laboratory services. The company was founded by Bob Kool and Jacques Havermans in 2003 and is headquartered in Geleen, the Netherlands. | Health Technology |
Matisse Pharmaceuticals BV
Matisse Pharmaceuticals BV BiotechnologyHealth Technology Matisse Pharmaceuticals BV engages in the development of therapeutic product for the treatment of sepsis. It offers The company was founded in 2014 and is headquartered in Geleen the Netherlands. | Health Technology |